Close Menu

NEW YORK (GenomeWeb) – Quidel announced after the close of market on Monday that it expects its fourth quarter revenues to be in the range of $132 million to $133 million, which would be up 15 to 16 percent from a year ago.

In Q4 2017, the San Diego-based maker of rapid diagnostic testing solutions and molecular diagnostic systems reported revenues of $114.9 million.

The preliminary results would be even with the consensus Wall Street estimate of $132.1 million.  

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.